Abstract
Nowadays, more and more heart failure patients need to be treated with
cardiac resynchronization therapy (CRT). Traditional epicardial pacing
has a high implantation failure rate and non-response rate, while left
ventricular endocardial pacing therapy exactly overcomes these
disadvantages, especially leadless endocardial pacing therapy has a
broad application prospect.